Rivia

RiviaRivia
R

Rivia

The data engine for clinical trial intelligence.

DR 352022Active15Zurich, Switzerland
Rate

About

Rivia provides a data engine for clinical trial intelligence, integrating thousands of heterogeneous data files in real time. It applies trial-specific scientific logic using a proprietary library of reusable configurations and feeds harmonized data directly into operational review workflows to enable more proactive decision-making. The company is also launching a suite of embedded AI agents, starting with Spark, which converts natural language into publication-grade clinical visualizations, and next-generation agents for proactive data quality monitoring and oversight.
HEADCOUNT
15
DOMAIN RATING
35
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Rivia do?

Rivia provides a data engine for clinical trial intelligence, integrating thousands of heterogeneous data files in real time. It applies trial-specific scientific logic using a proprietary library of reusable configurations and feeds harmonized data directly into operational review workflows to enable more proactive decision-making. The company is also launching a suite of embedded AI agents, starting with Spark, which converts natural language into publication-grade clinical visualizations, and…

How much funding has Rivia raised?

Rivia has raised a total of $15M in funding. The most recent round on record is Series A.

Where is Rivia headquartered?

Rivia is headquartered in Zurich, Switzerland.

When was Rivia founded?

Rivia was founded in 2022.

What industry does Rivia operate in?

Rivia operates in Biotechnology, Healthcare, Artificial Intelligence, Data Analytics, Clinical Trials.

How many employees does Rivia have?

Rivia has approximately 15 people on record.

What is Rivia's revenue?

StartupHub estimates Rivia's annual revenue at $1.4M (range $751K to $4.2M, 68% confidence), based on comparable companies in the sector.

What is Rivia's valuation?

StartupHub estimates Rivia's effective valuation at $60.9M (range $37.5M to $90.0M, 10% confidence), based on comparable companies in the sector.